Tandril SK
Diabetic retinopathy screening with AI-assisted analysis of retinal images for eye-care providers in Slovakia
Highlights
- Young companyFounded 2023
- New on EvolcAdded 2026-10-17
About Tandril SK
Tandril SK s.r.o. distributes a certified medical device for diabetic retinopathy screening: the iCare DRSplus non-mydriatic confocal fundus camera, paired with the iCare RETCAD® AI screening software and the iCare ILLUME Connect cloud for storing and sharing reports.
The company sells to healthcare providers, including optics, pharmacies, polyclinics and hospitals, and to specialists doing eye-background screening. The website does not describe pricing or revenue model beyond the product offering.
Tandril SK was founded in 2023 as a Slovak subsidiary of Tandril, a.s., which the website says was set up in the Czech Republic in 2022. The website lists Košice as the seat; no other offices are named.
Product: iCare DRSplus confocal fundus camera combined with iCare RETCAD AI screening software for diabetic retinopathy detection.
Financials
| FY2025 | FY2024 | FY20236 months | |
|---|---|---|---|
| Revenue | €49k | €52k | €14k |
| Growth | −6% | — | — |
| EBITDA | −€14k | −€14k | −€8k |
| Operating profit | −€14k | −€14k | −€8k |
| Net profit | −€15k | −€15k | −€8k |
| Net margin | −30.1% | −29.3% | −55.9% |
| Personnel costs | €23k | €23k | €4k |
| Total assets | €21k | €44k | €35k |
| Cash | €16k | €44k | €35k |
| Liabilities | €43k | €52k | €28k |
| Equity | −€23k | −€8k | €7k |
As filed with RÚZ (Slovak register of financial statements). Each year links to its statement.
Open jobs
Tech stack
- Apache
- Bootstrap
- Google Analytics 4
- Google reCAPTCHA
- PHP
- jQuery
